KRYS
Krystal Biotech, Inc.
$368.60
-6.08 (-1.62%)
At close · Jul 7
Market Cap
$10.87B
Shares
29,479,756
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-20 | 2026-05-15 | |
| 8-K | 2026-05-04 | — | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| DEF 14A | 2026-04-03 | — | |
| 8-K | 2026-02-17 | — | |
| 10-K | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-23 | — | |
| 8-K | 2025-11-03 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-08-04 | — | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-07-25 | — | |
| 8-K | 2025-07-24 | — | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-05-19 | — | |
| 8-K | 2025-05-13 | 2025-05-12 | |
| 8-K | 2025-05-06 | — | |
| 8-K | 2025-05-06 | 2025-05-05 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-04-28 | — | |
| DEF 14A | 2025-04-03 | — | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2025-02-19 | — | |
| 10-K | 2025-02-19 | 2024-12-31 | |
| 8-K | 2024-12-18 | — | |
| 8-K | 2024-12-12 | — | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-08-28 | — | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-05-21 | — | |
| 8-K | 2024-05-08 | 2024-05-07 | |
| 8-K | 2024-05-06 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| DEF 14A | 2024-04-04 | — | |
| 10-K | 2024-02-26 | 2023-12-31 | |
| 8-K | 2024-02-26 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-08-07 | 2023-08-02 | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-07-26 | — | |
| 8-K | 2023-05-23 | — | |
| 8-K | 2023-05-22 | — |
Showing 1–50 of 120 filings
Key facts
CIK
1711279
CUSIP
501147102
13F (30d)
13 filings
12 filers
Visit website
Investor relations